Lippman Evan 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Lippman Evan（CIK 2062834）在 1 家公司共报告 5 笔 SEC Form 4 内部人交易（最近一笔 2026-08-19）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-19 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Business Development | 卖出 | 18,600 | $680,291 |
| 2026-05-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Business Development | 买入 | 11,841 | $0 |
| 2026-05-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Business Development | 卖出 | 5,746 | $204,443 |
| 2026-05-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Business Development | 买入 | 74,008 | $0 |
| 2026-05-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | EVP, Business Development | 卖出 | 35,912 | $1.3M |
来源：SEC Form 4 申报文件 · 截至 2026-08-19